Last year, the SEC put out a proposal that -it's getting too easy to be an accredited investor -so they put out a proposal that we raise the wealth level to $2.5 million.
Second, the public markets loved biotech, so it was easytoraise money at attractive prices and provide exits for VC investors even when these companies were at relatively early stages of development.